Abbonarsi

Atrial cardiomyocytes orchestrate the development of profibrotic inflammatory profile associated with atrial fibrillation vulnerability - 12/05/23

Doi : 10.1016/j.acvdsp.2023.03.122 
Ewen Le Quilliec 1, , Charles-Alexandre LeBlanc 1, Rim Younes 1, Feng Xiong 1, Patrice Naud 1, Louis Villeneuve 1, Colombe Roy 1, Yan Fen Shi 1, Martin Sirois 1, Jean-François Tanguay 1, Jean-Claude Tardif 1, Roddy Hiram 2
1 Centre de recherche, Institut de cardiologie de Montréal, Montréal, Canada 
2 Département de médecine, faculté de médecine de l’université de Montréal, Montréal, Canada 

Corresponding author.

Riassunto

Introduction

Atrial fibrillation (AF) is the most common type of arrhythmia encountered clinically. AF risk factors include hypertension, respiratory diseases, obesity, or heart failure. Right heart disease (RHD) has also been described among AF risk factors associated with an atrial inflammatory profile leading to AF. Studies focusing on the cardiomyocytes (CM) orchestration of the tri-factorial relation between RHD, inflammation, and AF are rare. This project aims to characterize the proarrhythmogenic remodeling affecting atrial cardiomyocyte in a rat model of RHD induced by permanent pulmonary trunk constriction.

Objective

Characterize RHD induced electrophysiological and morphological CM remodeling leading to atrial inflammation and fibrosis, responsible for increased AF susceptibility.

Method

Pulmonary artery banding (PAB) was performed on Wistar rats weighing 225–275g to induce right-sided cardiac hypertrophy and dilation. Sham animals did not receive the PAB surgery. Cardiac echography and electrophysiological studies were performed in vivo on all animals before sacrifice, 21 days post-surgery. Optical mapping was performed ex-vivo on Langendorff-perfused hearts. Freshly isolated right ventricular (RV), as well as right and left atrial (RA and LA) CM, underwent contractility recording in vitro. Histological analyses were performed to assess myocardial fibrosis and Connexin-43 levels. Genes and protein levels were obtained by qPCR and Western-blot analyses respectively.

Results

PAB animals developed severe ventricular and atrial myocardial hypertrophy and dilation compared to Sham, as assessed by echocardiography. PAB animals were significantly more susceptible to AF compared to Sham. Freshly isolated CM revealed that overall CM size was increased in PAB animals, and contractile activity of CM was increased compared to the Sham rats. Analyses of targeted protein and gene expression levels by immunohistochemistry and qPCR analyses showed enhanced expression of fibrosis and inflammation-related compounds in whole-RA and RA CM from PAB, compared to Sham.

Conclusion

RHD induces electro-physiological remodeling influencing the RA CM contractile machinery which in turn, leads to the development of pro-arrhythmogenic substrate including atrial inflammation, fibrosis, and enhanced AF inducibility.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2023  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 15 - N° 2

P. 233-234 - maggio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • ST-segment slope change in V1 predict major events in Brugada syndrome
  • Pierre-Léo Laporte, Martino Vaglio, Isabelle Denjoy, Maison-Blanche Pierre, Fabio Badilini, Antoine Leenhardt, Fabrice Extramiana
| Articolo seguente Articolo seguente
  • Predict postoperative atrial fibrillation after cardiac surgery thanks to a preoperative macrophages functional in vitro test
  • Amine Tazibet, Eloise Woitrain, Sandro Ninni, David Montaigne

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.